Novel gastrointestinal surgeries that target diabetes, such as duodenal-jejunal bypass and ileal interposition, provide helpful clues to the mechanism of restored insulin sensitivity following bariatric surgery (5). The gene discussed is INS; the disease is diabetes mellitus.